Announcements Trials

Browse Landscape

Phase

Status

Recruiting 111 Active not recruiting 51 Not yet recruiting 29 Completed 13 Terminated 6 Suspended 2 Enrolling by invitation 2 Withdrawn 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 10 Prostatic Neoplasms 7 Lung Neoplasms 6 Recurrence 4 Multiple Myeloma 4 Lymphoma, B-Cell 4 Lymphoma 4 Colorectal Neoplasms 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Urologic Neoplasms 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Glioblastoma 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Vasculitis 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1

Interventions

zimberelimab 1 sacituzumab govitecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Triple Negative Breast Neoplasms × 90 days × Clear all

NCT07134556 2026-05-01

ADJUNCT

MedSIR

Phase 2 Withdrawn

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡